Abstract
Surfactant protein D (SP-D), expressed in respiratory epithelium, is important for modulating both innate and adaptive immunity against inhaled allergens. This chapter evaluates the key immunomodulatory role of SP-D in allergic airway inflammatory events. Studies have shown that SP-D ameliorated various cellular mechanisms implicated in pulmonary allergic reactions, including allergic eosinophilia through induction of apoptosis and clearance of activated eosinophils, and inhibition of basophils activation. In addition, blocking allergen-specific IgE synthesis, T cell proliferation, and hindrance to the binding of allergen-IgE complex to B lymphocytes are also brought about by SP-D. In vitro, a recombinant fragment of human SP-D, composed of homotrimeric neck and C-type lectin domains (rfhSP-D), binds to allergens derived from Aspergillus fumigatus, house dust mite and grass pollen in a calcium-dependent manner and inhibits specific IgE interaction with allergens. Murine models of hypersensitivity reactions, when treated with rfhSP-D, showed reduced levels of IgE, clearance of peripheral and pulmonary eosinophilia, and Th2 polarisation to Th1 type. SP-D knock-out mice accordingly show hypereosinophilia and predominantly exaggerated Th2 response following allergen challenge; these features can be ameliorated by rfhSP-D treatment. The current state of the filed appears to suggest that rfhSP-D is an excellent therapeutic immunomodulator in airway allergic diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Acharya KR, Ackerman SJ. Eosinophil granule proteins: form and function. J Biol Chem. 2014;289:17406–15.
Allinne J, Scott G, Lim WK, Birchard D, Erjefält JS, Sandén C, Ben L-H, Agrawal A, Kaur N, Kim JH. IL-33 blockade affects mediators of persistence and exacerbation in a model of chronic airway inflammation. J Allergy Clin Immunol. 2019;144:1624–37. e10
Borron PJ, Crouch EC, Lewis JF, Wright JR, Possmayer F, Fraher LJ. Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. J Immunol. 1998;161:4599–603.
Breiteneder H, Diamant Z, Eiwegger T, Fokkens WJ, Traidl-Hoffmann C, Nadeau K, O’hehir RE, O’mahony L, Pfaar O, Torres MJ. Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care. Allergy. 2019;74:2293–311.
Brinker KG, Martin E, Borron P, Mostaghel E, Doyle C, Harding CV, Wright JR. Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells. Am J Phys Lung Cell Mol Phys. 2001;281:L1453–63.
Carreto-Binaghi LE, Taylor ML. Surfactant proteins, SP-A and SP-D, in respiratory fungal infections: their role in the inflammatory response. Respir Res. 2016;17:1–7.
Cheng G, Ueda T, Numao T, Kuroki Y, Nakajima H, Fukushima Y, Motojima S, Fukuda T. Increased levels of surfactant protein A and D in bronchoalveolar lavage fluids in patients with bronchial asthma. Eur Respir J. 2000;16:831–5.
Conrad DH, Ford JW, Sturgill JL, Gibb DR. CD23: an overlooked regulator of allergic disease. Curr Allergy Asthma Rep. 2007;7:331–7.
Corrigan C, Haczku A, Gemou-Engesaeth V, Doi S, Kikuchi Y, Takatsu K, Durham S, Kay A. CD4 T-lymphocyte activation in asthma is accompanied by increased serum concentrations of interleukin-5: effect of glucocorticoid therapy. Am Rev Respir Dis. 1993;147:540–7.
Crawford A, Macleod M, Schumacher T, Corlett L, Gray D. Primary T cell expansion and differentiation in vivo requires antigen presentation by B cells. J Immunol. 2006;176:3498–506.
Crouch E, Parghi D, Kuan S, Persson A. Surfactant protein D: subcellular localization in nonciliated bronchiolar epithelial cells. Am J Phys Lung Cell Mol Phys. 1992;263:L60–6.
De Vooght V, Carlier V, Devos FC, Haenen S, Verbeken E, Nemery B, Hoet PH, Vanoirbeek JA. B-lymphocytes as key players in chemical-induced asthma. PLoS One. 2013;8:e83228.
Desch AN, Henson PM, Jakubzick CV. Pulmonary dendritic cell development and antigen acquisition. Immunol Res. 2013;55:178–86.
Drake LY, Iijima K, Hara K, Kobayashi T, Kephart GM, Kita H. B cells play key roles in th2-type airway immune responses in mice exposed to natural airborne allergens. PLoS One. 2015;10:e0121660.
Erpenbeck V, Ziegert M, Cavalet-Blanco D, Martin C, Baelder R, Glaab T, Braun A, Steinhilber W, Luettig B, Uhlig S. Surfactant protein D inhibits early airway response in Aspergillus fumigatus-sensitized mice. Clin Exp Allergy. 2006;36:930–40.
Esnault S, Kelly EA. Essential mechanisms of differential activation of eosinophils by IL-3 compared to GM-CSF and IL-5. Crit Rev Immunol. 2016;36(5):429–44.
Felton JM, Lucas CD, Rossi AG, Dransfield I. Eosinophils in the lung–modulating apoptosis and efferocytosis in airway inflammation. Front Immunol. 2014;5:302.
Fisher JH, Larson J, Cool C, Dow SW. Lymphocyte activation in the lungs of SP-D null mice. Am J Respir Cell Mol Biol. 2002;27:24–33.
Fitzgerald JM, Bleecker ER, Nair P, Korn S, Ohta K, Lommatzsch M, Ferguson GT, Busse WW, Barker P, Sproule S. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2016;388:2128–41.
Ghosh S, Hoselton SA, Schuh JM. μ-chain–deficient mice possess B-1 cells and produce IgG and IgE, but not IgA, following systemic sensitization and inhalational challenge in a fungal asthma model. J Immunol. 2012;189:1322–9.
Haczku A. Protective role of the lung collectins surfactant protein A and surfactant protein D in airway inflammation. J Allergy Clin Immunol. 2008;122:861–79.
Håkansson K, Lim NK, Hoppe H-J, Reid KB. Crystal structure of the trimeric α-helical coiled-coil and the three lectin domains of human lung surfactant protein D. Structure. 1999;7:255–64.
Hamelmann E, Takeda K, Haczku A, Cieslewicz G, Shultz L, Hamid Q, **ng Z, Gauldie J, Gelfand EW. Interleukin (IL)-5 but Not Immunoglobulin E Reconstitutes Airway Inflammation and Airway Hyperresponsiveness in IL-4–Deficient Mice. Am J Respir Cell Mol Biol. 2000;23:327–34.
Hansen S, Lo B, Evans K, Neophytou P, Holmskov U, Wright JR. Surfactant protein D augments bacterial association but attenuates major histocompatibility complex class II presentation of bacterial antigens. Am J Respir Cell Mol Biol. 2007;36:94–102.
Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, Johnson LL, Swain SL, Lund FE. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol. 2000;1:475–82.
Hartl D, Griese M. Surfactant protein D in human lung diseases. Eur J Clin Investig. 2006;36:423–35.
Hellings PW, Fokkens WJ, Bachert C, Akdis CA, Bieber T, Agache I, Bernal-Sprekelsen M, Canonica GW, Gevaert P, Joos G. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis–A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017;72:1297–305.
Holmskov U, Malhotra R, Sim RB, Jensenius JC. Collectins: collagenous C-type lectins of the innate immune defense system. Immunol Today. 1994;15:67–74.
Hortobágyi L, Kierstein S, Krytska K, Zhu X, Das AM, Poulain F, Haczku A. Surfactant protein D inhibits TNF-α production by macrophages and dendritic cells in mice. J Allergy Clin Immunol. 2008;122:521–8.
Jeffery PK, Haahtela T. Allergic rhinitis and asthma: inflammation in a one-airway condition. BMC Pulmon Med. 2006;6:S5.
Kishore U, Wang J-Y, Hoppe H-J, Reid KB. The α-helical neck region of human lung surfactant protein D is essential for the binding of the carbohydrate recognition domains to lipopolysaccharides and phospholipids. Biochem J. 1996;318:505–11.
Kishore U, Greenhough TJ, Waters P, Shrive AK, Ghai R, Kamran MF, Bernal AL, Reid KB, Madan T, Chakraborty T. Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol Immunol. 2006;43:1293–315.
Koopmans J, Van Der Zee J, Krop E, Lopuhaä C, Jansen H, Batenburg J. Serum surfactant protein D is elevated in allergic patients. Clin Exp Allergy. 2004;34:1827–33.
Kratzer B, Pickl WF. Years in review: recent progress in cellular allergology. Int Arch Allergy Immunol. 2016;169:1–12.
Kuruvilla ME, Lee FE-H, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol. 2019;56:219–33.
Lin K-W, Jen KY, Suarez CJ, Crouch EC, Perkins DL, Finn PW. Surfactant protein D-mediated decrease of allergen-induced inflammation is dependent upon CTLA4. J Immunol. 2010;184:6343–9.
Lindell DM, Berlin AA, Schaller MA, Lukacs NW. B cell antigen presentation promotes Th2 responses and immunopathology during chronic allergic lung disease. PLoS One. 2008;3:e3129.
Linton P-J, Bautista B, Biederman E, Bradley ES, Harbertson J, Kondrack RM, Padrick RC, Bradley LM. Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J Exp Med. 2003;197:875–83.
Liu CF, Chen YL, Shieh CC, Yu CK, Reid K, Wang JY. Therapeutic effect of surfactant protein D in allergic inflammation of mite-sensitized mice. Clin Exp Allergy. 2005;35:515–21.
Macaubas C, Dekruyff RH, Umetsu DT. Respiratory tolerance in the protection against asthma. Curr Drug Target Inflammat Allergy. 2003;2:175–86.
Madan T, Kishore U, Shah A, Eggleton P, Strong P, Wang J-Y, Aggrawal S, Sarma P, Reid K. Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils. Clin Exp Immunol. 1997;110:241–9.
Madan T, Kishore U, Singh M, Strong P, Clark H, Hussain EM, Reid KB, Sarma PU. Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens. J Clin Invest. 2001;107:467–75.
Mahajan L, Madan T, Kamal N, Singh VK, Sim RB, Telang SD, Ramchand CN, Waters P, Kishore U, Sarma PU. Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages. Int Immunol. 2008;20:993–1007.
Malhotra R, Thiel S, Reid K, Sim R. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med. 1990;172:955–9.
Malhotra R, Haurum J, Thiel S, Sim RB. Interaction of C1q receptor with lung surfactant protein A. Eur J Immunol. 1992;22:1437–45.
Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 1994;12:991–1045.
Méndez-EnrÃquez E, Hallgren J. Mast cells and their progenitors in allergic asthma. Front Immunol. 2019;10:821.
Moser M, Murphy KM. Dendritic cell regulation of Th 1-Th 2 development. Nat Immunol. 2000;1:199–205.
Novak N, Allam JP, Betten H, Haberstok J, Bieber T. The role of antigen presenting cells at distinct anatomic sites: they accelerate and they slow down allergies. Allergy. 2004;59:5–14.
Ooi EH, Wormald PJ, Carney AS, James CL, Tan LW. Surfactant protein d expression in chronic rhinosinusitis patients and immune responses in vitro to Aspergillus and alternaria in a nasal explant model. Laryngoscope. 2007;117:51–7.
Palm NW, Rosenstein RK, Medzhitov R. Allergic host defences. Nature. 2012;484:465–72.
Pawankar R. Allergic diseases and asthma: a global public health concern and a call to action. World Allergy Organ J. 2014;7(1):12.
Persson A, Chang D, Rust K, Moxley M, Longmore W, Crouch E. Purification and biochemical characterization of CP4 (SP-D), a collagenous surfactant-associated protein. Biochemistry. 1989;28:6361–7.
Polverino E, Dimakou K, Hurst J, Martinez-Garcia M-A, Miravitlles M, Paggiaro P, Shteinberg M, Aliberti S, Chalmers JD. The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions. Eur Respir J. 2018;2018:52.
Possmayer F. Pulmonary perspective. Am Rev Respir Dis. 1988;138:990.
Qaseem AS, Singh I, Pathan AA, Layhadi JA, Parkin R, Alexandra F, Durham SR, Kishore U, Shamji MH. A recombinant fragment of human surfactant protein D suppresses basophil activation and T-helper type 2 and B-cell responses in grass pollen–induced allergic inflammation. Am J Respir Crit Care Med. 2017;196:1526–34.
Schaub B, Westlake R, He H, Arestides R, Haley K, Campo M, Velasco G, Bellou A, Hawgood S, Poulain FR. Surfactant protein D deficiency influences allergic immune responses. Clin Exp Allergy. 2004;34:1819–26.
Schleh C, Rothen-Rutishauser BM, Blank F, Lauenstein HD, Nassimi M, Krug N, Braun A, Erpenbeck VJ, Gehr P, Hohlfeld JM. Surfactant Protein D modulates allergen particle uptake and inflammatory response in a human epithelial airway model. Respir Res. 2012;13:1–10.
Singh M, Madan T, Waters P, Parida SK, Sarma PU, Kishore U. Protective effects of a recombinant fragment of human surfactant protein D in a murine model of pulmonary hypersensitivity induced by dust mite allergens. Immunol Lett. 2003;86:299–307.
Sorensen GL. Surfactant protein D in respiratory and non-respiratory diseases. Front Med. 2018;5:18.
Staubach P, Metz M, Chapman-Rothe N, Sieder C, Bräutigam M, Maurer M, Weller K. Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data. Allergy. 2018;73:576–84.
Takeda K, Miyahara N, Rha Y-H, Taube C, Yang E-S, Joetham A, Kodama T, Balhorn AM, Dakhama A, Duez C. Surfactant protein D regulates airway function and allergic inflammation through modulation of macrophage function. Am J Respir Crit Care Med. 2003;168:783–9.
Trischler J, Lieb A, Arnold M, Schulze J, Rosewich M, Schubert R, Bottoli I, Zielen S. Omalizumab effectively protects against early and late allergic responses in asthma after 4 weeks. Allergy. 2017;72:1912–5.
Vass G, Scanlon S, Beers M, Haczku A. Surfactant protein (SP)-D suppresses antigenic and mitogenic T cell activation in vitro. J Allergy Clin Immunol. 2004;113:S252.
Von Bredow C, Hartl D, Schmid K, Schabaz F, Brack E, Reinhardt D, Griese M. Surfactant protein D regulates chemotaxis and degranulation of human eosinophils. Clin Exp Allergy. 2006;36:1566–74.
Voskamp A, Kormelink TG, Van Wijk RG, Hiemstra P, Taube C, De Jong E, Smits HH. Modulating local airway immune responses to treat allergic asthma: lessons from experimental models and human studies. Semin Immunopathol. 2020;2020:1–16.
Wang J-Y, Reid KB. The immunoregulatory roles of lung surfactant collectins SP-A, and SP-D, in allergen-induced airway inflammation. Immunobiology. 2007;212:417–25.
Wang J-Y, Kishore U, Lim B-L, Strong P, Reid KB. Interaction of human lung surfactant proteins A and D with mite (Dermatophagoides pteronyssinus) allergens. Clin Exp Immunol. 1996;106:367–73.
Wang J-Y, Shieh C-C, You P-F, Lei H-Y, Reid KB. Inhibitory effect of pulmonary surfactant proteins A and D on allergen-induced lymphocyte proliferation and histamine release in children with asthma. Am J Respir Crit Care Med. 1998;158:510–8.
Winkler C, Hohlfeld JM. Surfactant and allergic airway inflammation. Swiss Med Wkly. 2013;143:w13818.
Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol. 2005;5:58–68.
Yousefi S, Sharma SK, Stojkov D, Germic N, Aeschlimann S, Ge MQ, Flayer CH, Larson ED, Redai IG, Zhang S. Oxidative damage of SP-D abolishes control of eosinophil extracellular DNA trap formation. J Leukoc Biol. 2018;104:205–14.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Singh, I., Beirag, N., Kishore, U., Shamji, M.H. (2021). Surfactant Protein D: A Therapeutic Target for Allergic Airway Diseases. In: Kishore, U., Madan, T., Sim, R.B. (eds) The Collectin Protein Family and Its Multiple Biological Activities. Springer, Cham. https://doi.org/10.1007/978-3-030-67048-1_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-67048-1_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-67047-4
Online ISBN: 978-3-030-67048-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)